Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.
about
Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgeryOngoing clinical trials of the pleiotropic effects of statinsLipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley ratsDifferential reactivity of human mammary artery and saphenous vein to prostaglandin E(2) : implication for cardiovascular grafts.Cholesterol lowering modulates T cell function in vivo and in vitromRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease.Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases.The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatologyStatins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.Pharmacological modulation of plaque instability.Curcumin Alleviates oxLDL Induced MMP-9 and EMMPRIN Expression through the Inhibition of NF-κB and MAPK Pathways in MacrophagesRole of angiotensin II receptor blockers in atherosclerotic plaque stability.Cyclooxygenase products and atherosclerosisEffects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomyCarotid atherosclerotic plaque stenosis: the stabilizing role of statins.Pleiotropic effects of statins: new therapeutic targets in drug design.Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages.Tirofiban: a critical reappraisal of the clinical use, recent developments and future perspectives.Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression.Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathwaysAtorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques.Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.Raging the War Against Inflammation With Natural Products
P2860
Q24201360-73D87BE6-6974-4F80-B77F-AAC26264C0D5Q28219321-43F8736A-3E89-41D6-9FBC-466D27DA3637Q33824051-13AFDD3F-30FC-418C-9496-A629E464A711Q34269548-804FE8B2-75DA-47E8-8F24-B0427F3388DAQ35036193-D154F09D-F43E-4252-A603-B89EA7A59F4FQ35125249-FE2FBD7E-2E62-4420-8740-7F918C17E264Q35588934-6ACAFF86-B612-4E01-8789-17894639BA81Q35911136-B4EA3C40-3E70-457D-B69E-B7DEA9775173Q36059492-79080C06-EF4E-41FC-A5E5-4B059EE28066Q36088110-39863182-2A78-49A0-BA6E-BAED6CE11F43Q36283516-82015194-E9BE-4AA3-AE9D-5FF1FEE317DFQ36297688-382F2BBB-6151-4C68-8B24-61B7B257B85DQ36382568-2906CF9F-ECC1-4CD0-BF0C-CF7786BA0E22Q37071164-5BB32169-D745-4119-A76F-5FFC2CB575D0Q37641097-7A32E2EC-EF94-4EE2-A203-BFD29210E1FFQ38251322-FDAB771A-D2B0-4A2B-88E5-D5D2EA04E5BEQ38825843-E1D1E68A-39EF-485D-A02E-B89146AD5FE2Q40341822-C04CFD70-CAA2-469E-BCB1-B3B55B624F9AQ40361591-39559E4F-6F5A-443C-82C3-C792A3603929Q40578128-A5D11282-879A-48BA-A5CC-F31E001DC651Q41880179-E15B3683-2A1A-4F96-9FC1-0A0EB12E00A7Q41894332-44A2E2B6-743C-4505-BA74-CEC29C66CF43Q41950529-B79FED4B-BC7B-4111-A691-9C566687FA32Q46297555-F7D11DFA-1393-4283-ABF1-132574F656C9Q46844231-5F810C4F-95E5-4A0C-81BA-57A5D9FF9F16Q51064866-42999547-1C15-4B47-B095-C3D84DB5D011Q58758818-52057129-2D89-45B8-AC80-CB33A213557C
P2860
Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Suppression of the functionall ...... laque stabilization in humans.
@en
Suppression of the functionall ...... laque stabilization in humans.
@nl
type
label
Suppression of the functionall ...... laque stabilization in humans.
@en
Suppression of the functionall ...... laque stabilization in humans.
@nl
prefLabel
Suppression of the functionall ...... laque stabilization in humans.
@en
Suppression of the functionall ...... laque stabilization in humans.
@nl
P2093
P1433
P1476
Suppression of the functionall ...... laque stabilization in humans.
@en
P2093
Andrea Mezzetti
Annalisa Iezzi
Barbara Pini
Domenico De Cesare
Francesco Chiarelli
Francesco Spigonardo
Franco Cuccurullo
Guido Bajocchi
Luciano Artese
Maria Fazia
P304
P356
10.1161/01.CIR.0000056530.03783.81
P407
P577
2003-03-01T00:00:00Z